McConeghy Kevin W, Mikolich Dennis J, LaPlante Kerry L
Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.
Pharmacotherapy. 2009 Mar;29(3):263-80. doi: 10.1592/phco.29.3.263.
Methicillin-resistant Staphylococcus aureus (MRSA) bacteria are a common cause of hospital- and community-acquired infections. Persons may have asymptomatic colonization with MRSA in the nares, axillae, perineum, or groin. Since MRSA colonization often precedes infection, and infection is associated with significant morbidity and mortality, there is great interest in preventing the transmission of MRSA and decolonizing persons who harbor these bacteria. We provide an evidence-based review of MRSA decolonization agents. Our search strategy included the databases of the Cochrane Central Register of Controlled Trials, MEDLINE (1962-May 2008), and EMBASE (1980-May 2008). To identify unpublished trials, abstract books from appropriate major scientific meetings were hand searched, manufacturers were contacted, and pharmacology references were researched for available commercial products, formulations, adverse events, and dosing. The most extensive research in MRSA decolonization has been conducted with mupirocin, which is applied to the anterior nares 2-3 times/day for 5 days. Increased use is correlated to resistance development; therefore, routine decolonization is not prudent unless MRSA colonization is confirmed in the nares or other site. Retapamulin is under investigation for use in nares decolonization. If total body decolonization is necessary, bathing or showering with an antiseptic agent such as chlorhexidine gluconate is recommended in combination with mupirocin applied to the nares to improve the likelihood of eradication. Oral antibiotics have been evaluated for use in decolonization of the skin and nares but should be considered only in conjunction with topical agents and when all other decolonization attempts and environmental controls have been exhausted. Homeopathic and investigational agents may also be effective. Although mupirocin is the standard of care for decolonization of MRSA, several agents demonstrate efficacy and many merit further investigation.
耐甲氧西林金黄色葡萄球菌(MRSA)是医院获得性感染和社区获得性感染的常见病因。人们的鼻腔、腋窝、会阴或腹股沟可能有无症状的MRSA定植。由于MRSA定植通常先于感染发生,且感染与显著的发病率和死亡率相关,因此预防MRSA传播以及清除携带这些细菌的人的定植受到了极大关注。我们对MRSA去定植药物进行了循证综述。我们的检索策略包括Cochrane对照试验中央注册库、MEDLINE(1962年 - 2008年5月)和EMBASE(1980年 - 2008年5月)数据库。为了识别未发表的试验,我们手工检索了适当的主要科学会议的摘要集,联系了制造商,并查阅了药理学参考文献以获取可用的商业产品、制剂、不良事件和剂量信息。在MRSA去定植方面进行的最广泛研究是使用莫匹罗星,它每天应用于前鼻孔2 - 3次,持续5天。使用增加与耐药性产生相关;因此,除非在鼻孔或其他部位确认有MRSA定植,否则常规去定植并不明智。瑞他帕林正在进行用于鼻孔去定植的研究。如果需要全身去定植,建议使用葡萄糖酸洗必泰等抗菌剂进行沐浴或淋浴,同时将莫匹罗星应用于鼻孔,以提高根除的可能性。口服抗生素已被评估用于皮肤和鼻孔的去定植,但仅应在与局部用药联合使用且所有其他去定植尝试和环境控制措施均无效时考虑。顺势疗法药物和研究性药物也可能有效。虽然莫匹罗星是MRSA去定植的标准治疗药物,但几种药物显示出疗效,许多药物值得进一步研究。